Gene · 54
Papers2,683
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,683
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Periodontal ligament cells-derived exosomes promote osteoclast differentiation via modulating macrophage polarization. | Sci Rep | 2024 | 38233593 | PubTator, text mining | PubMed |
| Plant-derived natural medicines for the management of osteoporosis: A comprehensive review of clinical trials. | J Tradit Complement Med | 2024 | 38223808 | PubTator, text mining | PubMed |
| Real-world usage of Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD) biomarkers in nephrology practices. | Clin Kidney J | 2024 | 38223338 | PubTator, text mining | PubMed |
| PIVKA‑II is associated with liver function, bone metabolism, and muscle function in patients with liver disease. | Biomed Rep | 2024 | 38222867 | PubTator, text mining | PubMed |
| Bilateral cochlear implants in a case of spondyloenchondrodysplasia with sensorineural hearing loss: Case report. | Int J Surg Case Rep | 2024 | 38219511 | PubTator, text mining | PubMed |
| Iron role paradox in nerve degeneration and regeneration. | Physiol Rep | 2024 | 38176709 | PubTator, text mining | PubMed |
| Oral Sodium Bicarbonate and Bone Turnover in CKD: A Secondary Analysis of the BASE Pilot Trial. | J Am Soc Nephrol | 2024 | 38170601 | PubTator, text mining | PubMed |
| A TLR4/TRAF6-dependent signaling pathway mediates NCoR coactivator complex formation for inflammatory gene activation. | Proc Natl Acad Sci U S A | 2024 | 38165941 | PubTator, text mining | PubMed |
| Efficacy and safety of denosumab treatment for Korean patients with Stage 3b-4 chronic kidney disease and osteoporosis. | Korean J Intern Med | 2024 | 38145616 | PubTator, text mining | PubMed |
| Increased bone resorption that outpaces increased bone formation: An important pathology of rapidly destructive coxarthrosis. | J Orthop Res | 2024 | 38044471 | PubTator, text mining | PubMed |
| Levels of vitamin D and a bone resorption marker in the sera of young women with alcohol use disorder. | J Addict Dis | 2024 | 37950604 | PubTator, text mining | PubMed |
| Evaluating the Clinical Efficacy of Teriparatide and Denosumab Combination Therapy in Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis. | Altern Ther Health Med | 2024 | 37944971 | PubTator, text mining | PubMed |
| Tenapanor for peritoneal dialysis patients with hyperphosphatemia: a phase 3 trial. | Clin Exp Nephrol | 2024 | 37910313 | PubTator, text mining | PubMed |
| The Use of Bone-Turnover Markers in Asia-Pacific Populations. | Ann Lab Med | 2024 | 37869778 | PubTator, text mining | PubMed |
| The relationship between length of denosumab treatment for postmenopausal osteoporosis and serum TRAcP5b measured six months after the last injection. | Osteoporos Int | 2024 | 37783758 | PubTator, text mining | PubMed |
| Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1. | Clin Trials | 2024 | 37772407 | PubTator, text mining | PubMed |
| Study on the diagnosis and pathogenic relationship of primary spontaneous pneumothorax with the expression of TRACP5b and 25-OH VD assisted chest CT. | Panminerva Med | 2024 | 37768566 | PubTator, text mining | PubMed |
| Plasma proteins as potential biomarkers of aging of single tissue and cell type. | Biogerontology | 2024 | 37707684 | PubTator, text mining | PubMed |
| Effects of partial replacement of red and processed meat with non-soya legumes on bone and mineral metabolism and amino acid intakes in BeanMan randomised clinical trial. | Br J Nutr | 2024 | 37424311 | PubTator, text mining | PubMed |
| Spondyloenchondrodysplasia with immune dysregulation related to ACP5. A report of 4 cases. | Arch Argent Pediatr | 2024 | 37382551 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54/papers?page=14